At the close on September 7, 2026, Novo Nordisk stock finished at DKK 298.62 on Nasdaq Copenhagen, d

Eli Lilly is worth 5.5x Novo Nordisk but earns nowhere near 5.5x more. Here

Novo Nordisk stock faces pressure after the company halted two additional ziltivekimab heart-drug tr

Novo Nordisk shares stay weak despite strong pediatric obesity data; analysts split ahead of Sept 21

Novo Nordisk A/S (NYSE:NVO) has delivered encouraging late-stage data for Wegovy in younger children, with its STEP Young trial showing that 40.4% of children aged 6 to under 12 were no longer classified as having obesity after 68 weeks of semaglutide treatment, compared with none in the placebo group. The trial met its primary endpoint, […]

The megablockbuster helped 40% of children reduce BMI below the obesity threshold at 68 weeks, compared with 0% for placebo, in the STEP Young trial.

The drug helped older kids lose weight in earlier studies but this marks the first trial looking at its effect on young children.

Despite strong STEP-Young results, Novo Nordisk shares stay flat as investors weigh pipeline setback

Novo Nordisk says phase 3 STEP Young data showed semaglutide reduced BMI more than placebo in children aged 6 to under 12 with obesity.

Novo Nordisk stock is trading slightly lower after the company halted two heart drug studies while s